Join

or

Existing user? Login

Biosimilars

Pharmacists have good understanding of biosimilars but concerns over switching, study results show

Pharmacists have the greatest knowledge of biosimilars across surveyed healthcare professionals but share concerns about the safety and efficacy of switching patients to the medicines.

 

Lantus Insulin glargine injection soloution cartridges

Source: Alamy

Researchers found that pharmacists had the greatest knowledge and awareness of biosimilars with 84.8% being able to accurately define them, compared with 76.6% of consultants/registrars and 53.4% of nurses

UK pharmacists have a high level of understanding of biosimilars but have concerns about the safety and efficacy of switching patients to the drugs, research has shown[1].

The study, published in the International Journal of Pharmacy Practice (30 August 2018), involved a web-based survey completed by 150 medical consultants/registrars, 58 nurses and 26 pharmacists specialising in dermatology, diabetes, gastroenterology or rheumatology. The survey asked about their knowledge and experience of infliximab and insulin glargine biosimilars.

The results showed that pharmacists had the greatest knowledge and awareness of biosimilars, with 84.8% who could accurately define them, compared with 76.6% of consultants/registrars and 53.4% of nurses.

Concerns about safety and efficacy when switching patients to biosimilars were high among all the healthcare professionals, but nurses had a higher level of major concerns than doctors and pharmacists about the safety and efficacy of biosimilars when initiating them in biologic-naive patients.

The researchers said that as more biosimilars become available, knowledge gaps will likely arise among healthcare professionals.

“There is a variance in the level of understanding and attitude to biosimilars between professions, with a good level of understanding in medical consultants and pharmacists, but a lower level for nurses,” they said. 

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205528

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and BNF for Children

    Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50
  • BNF and BNF for Children

    Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50
  • Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00
  • Essentials of Economic Evaluation in Healthcare

    An introduction to economic evaluation specific to healthcare, for those with little or no knowledge of economics. Covers cost effectiveness, cost utility and cost benefit analysis.

    £33.00
  • Information Technology for Pharmacists

    £22.00

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

orlistat kaufen

viagra generika günstig kaufen deutschland

dove comprare kamagra